Investigating the efficacy of a new diuretic in dogs with pulmonary oedema

Ironside, Vicky; Saxton, Julie; Collins, Stephen; Braidwood, Lynne
December 2014
Veterinary Record: Journal of the British Veterinary Association;12/13/2014, Vol. 175 Issue 23, p598
Academic Journal
The article discusses a study which investigates the efficacy of diuretic in dogs with pulmonary oedema.


Related Articles

  • Diuretics: a review for the pharmacist. Smith, Haley // South African Pharmaceutical Journal;2014, Vol. 81 Issue 7, p18 

    Diuretics are among the most commonly prescribed medications. They inhibit electrolyte reabsorption from the lumen of the nephron, increasing osmolarity and enhancing water and electrolyte excretion. It is important to note that there is a delicate balance between dietary sodium intake and...

  • Hematocrit level correlates with lungs resistivity in elderly patients with cardiogenic pulmonary edema. Arad, Marina; Adunsky, Avraham; Zlochiver, Sharon; Barnea, Ofer; Abboud, Shimon // Communications & Network;Nov2010, Vol. 2 Issue 4, p76 

    Regular monitoring of pulmonary congestion in cardiogenic pulmonary edema (CPE) patients is necessary for its adequate management via pharmaceutical treatment. It is well known that the development of CPE is accompanied with an increase in hematocrit, plasma protein concentration and colloid...

  • bumetanide. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p132 

    An encyclopedia entry for "bumetanide" is presented. It refers to a powerful, short-acting loop diuretic agent which is used for treatment of oedema resulting from heart failure, nephroticsyndrome, or cirrhosis. The drug may be administered through injection for the emergency treatment of...

  • High-altitude pulmonary edema presenting 18 hours after descent. Strote, Jared; Prutkin, Jordan // Wilderness & Environmental Medicine;Summer2006, Vol. 17 Issue 2, p137 

    High-altitude pulmonary edema (HAPE) is a potentially life-threatening condition that is rapidly and definitively treated by descent. We report a case of worsening HAPE, presenting more than 18 hours after descent to sea level. The patient was treated with diuretics, calcium channel blockers,...

  • Diuretic for managing canine heart failure.  // Veterinary Record: Journal of the British Veterinary Association;8/8/2015, Vol. 177 Issue 6, p157 

    The article offers information on the Libeo canine heart failure management diuretic from Ceva Animal Health.

  • Pulmonary oedema in a hunting dog: a case report. AGUDELO, C. F.; SCHANILEC, P. // Veterinární Medicína;2015, Vol. 60 Issue 8, p446 

    This case report describes an episode of acute dyspnoea after hunting in a Dachshund dog. Thoracic radiographs confirmed pulmonary oedema. Echocardiography, electrocardiography and cardiac markers were within normal limits. Based on the history, clinical signs and other diagnostic tests this...

  • Management of acute heart failure in the emergency department. Fenwick, Rob // Emergency Nurse;Dec2015, Vol. 23 Issue 8, p26 

    Acute heart failure (AHF) is a leading cause of hospital admission in the UK and is associated with significant mortality. The National Institute for Health and Care Excellence (2014) has published guidelines for the management of AHF but, after a clinical event in which a patient's management...

  • Bilateral reexpansion pulmonary edema associated with pleural empyema: a case report. Paksu, Muhammet; Paksu, Sule; Akgün, Muhammet; Kalaycı, Ayhan; Baysal, Kemal; Paksu, Muhammet Sukru; Akgün, Muhammet; Kalaycı, Ayhan Gazi // European Journal of Pediatrics;Sep2011, Vol. 170 Issue 9, p1205 

    Reexpansion pulmonary edema is an uncommon complication following rapid reexpansion of the lungs. The risk increases with a prolonged duration of pulmonary collapse, the amount of drained liquid or air, and with decreased time of draining. Treatment is supportive. In general, the prognosis is...

  • Pemetrexed.  // Reactions Weekly;12/16/2006, Issue 1132, p21 

    The article presents a case report on the adverse effect of pemetrexed treatment on a 56-year-old man with lung adenocarcinoma. After being given pemetrexed for a 21-day cycle, the man developed blepharoedema on the eighth day of the second course of treatment. His oedema did not improve despite...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics